APA način citiranja

Camelo, S., Latil, M., Veillet, S., Dilda, P. J., & Lafont, R. (2020). Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors. Oxid Med Cell Longev.

Čikaški stil citiranja

Camelo, Serge, Mathilde Latil, Stanislas Veillet, Pierre J. Dilda, i René Lafont. "Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids As Neuroprotectors." Oxid Med Cell Longev 2020.

MLA način citiranja

Camelo, Serge, et al. "Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids As Neuroprotectors." Oxid Med Cell Longev 2020.